AHPBA Research Development Grant

AHPBA 2021 Research Development Grant – Apply by November 2nd at 11:59pm EST

The purpose of this award is to provide the opportunity for Junior faculty to perform research during the 2021 – 2022 academic year. Junior Faculty is defined as less than 7 years from fellowship training graduation (e.g. completed fellowship training no sooner than August 1, 2013). Exceptions to time from training and meeting attendance will be considered for leaves of absence during initial faculty appointment including but not limited to personal or family illness, military deployment, maternity leave, or others considered on a case-by-case basis. The research can be clinical, outcomes, translational, or basic science, but must focus on the liver, pancreas, or biliary system. Applicants must have a minimum of 20% protected time verified by dept chair to conduct said research, and the project must be feasible to complete within the one-year award time frame. The amount of the award is $30,000. 

Application Checklist

  • UPLOAD Your CV (5-page limit, NIH format)
  • UPLOAD Your Research Proposal (One, single file!)
    Format: 3 pages maximum with figures embedded; excluding references, minimum 11 point Arial font with 0.5 inch margins; exceptions for figure legends which must be reasonably legible
    Must include the following components:
    • Project narrative (NIH Format, limit 3 sentences)
    • Background information & Preliminary Data (embedded figures and tables – limit 5)
    • Specific aims
    • Methods and design
    • Significance/Innovation
  • UPLOAD Budget Justification (1-page limit, no indirect costs allowed)
  • UPLOAD Literature Cited (1-page limit)
  • UPLOAD Appropriate institutional approvals (e.g., IRB, IACUC (Animal Studies Committee) approval letters)
  • UPLOAD 2 Letters of Recommendation 
    • 1 from your department chair (The letter must indicate that “Fellowship funds will not be used for overhead and that the monies provided are for salary and direct costs only”. Letter must also confirm that some form of protected time will occur for this project to be successful).
    • 1 from a professional or personal reference that can speak to your commitment to HPB surgery, commitment to research, and ability to complete the project.
  • Brief Personal Statement: Please describe your career goals, career development plan, current mentorship, and how this award would advance your career (limit 350 words)

2020

Rory Smoot MDMD, MSE

Mayo Clinic

Nanovesicle-mediated Targeting of YAP Activation in Cholangiocarcinoma to Enhance Chemotherapy Sensitivity

2019

Joshua Leinwand MD, MSE

NYU Langone

The Microbiome and Regulation of Hepatic Immunity

Lawrence Delrosario MD

University of Michigan

Diabetes-Mediated Enhancement of Pancreatic Tumorigenesis: Exploring The Role of Adipocyte-Cancer Crosstalk

2018

Bradley A. Krasnick MD

Washington University/ Barnes Jewish Hospital

A Humanized Mouse Model of Pancreatic Ductal Adenocarcinoma

Mohammad Raheel Jajja MD

Emory University

Peptide Nanoprobes For Multi-Receptor-Targeting and Optical Imaging of Colorectal Liver Metastases

2017

Alexander Gaidarski, MD

University of Miami Miller School of Medicine

Role of p16 in Sensitivity to MEK Inhibition in Pancreatic Cancer

Georgios Gemenetzis, MD

Johns Hopkins University School of Medicine

Circulating tumor cells in pancreatic adenocarcinoma: effect of cancer-directed therapy and ex vivo modeling

Read research update

2016

Derek J. Erstad, MD

Massachusetts General Hospital

Molecular MR imaging of Desmoplasia after Neoadjuvannt Treatment of Pancreatic Cancer

Read research update

Nicholas G. Berger, MD

Medical College of Wisconsin

Determination of Xanthohumol inhibits Notch signaling in vivo and increases the survival and reduces tumor progression in HCC liver xenograft

Read research update

2015

Samer Tohme, MD

University of Pittsburgh

The Role of Neutrophil Extracellular Traps in Liver Sterile Inflammation

Supported By: AHPB Foundation

Read research update

Ashton Connor, MD

University of Toronto

Genomic and Transcriptomic Characterization of Pancreatic Cancer

Supported By: AHPBA

Read research update

2014

Jonathan Hernandez, MD

Memorial Sloan-Kettering Cancer Center

Characterization of Dormancy and Outgrowth for Metastatic Pancreatic Cancer in the Liver

Supported By: AHPBA

Read research update

2013

Physiology/Biology Research Grant
Stephanie Greco, MD

New York University School of Medicine - Department of Surgery

Regulation of Acute Pancreatitis by C-type Lectin Receptors

Supported By: AHPBA

Read research update

2012

Oncology Research Grant
Kevin Soares, MD

Johns Hopkins Hospital Surgery

Combinatorial Immunotherapy and the Manipulation of Tumor Microenvironment in the Treatment of Pancreatic Cancer

Supported By: AHPBA

Read research update

2011

Oncology Research Grant
Michele Babicky, MD

University of California, San Diego Medical Center

Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer

Supported By: AHPBA

2008

Surgical Technology Assessment and Outcomes Research Grant
Peter Nau, MD

The Ohio State University Medical Center Center for Minimally Invasive Surgery

Development of a Novel Repair Technique for latrogenic Common Bile Duct Injuries with a Biosynthetic Absorbable Graft

Supported By: Covidien and AHPBA

Physiology/Biology Research Grant
Kendra D. Conzen. MD

Washington University

The Role of HMGB1 in Steatotic Livers following Ischemia/Reperfusion

Supported By: Ethicon, Inc. and AHPBA

Oncology Research Grant
Wigdan Al-Sukhni

University of Toronto

An analysis of germline genomic copy-number variation to identify disease-associated gene(s) in familial pancreatic cancer

Supported By: Sanofi Aventis and AHPBA

2007

Covidien Surgical Technology Assessment
Lia Roque Assumpcao, MD

Johns Hopkins University Hospital

Application of Novel, High Resolution, and Freehand Ultrasound Elasticity Imaging in Liver Surgery

Sanofi-anventis HPB Oncology
Bedabrata Sarkar, MD

University of Michigan Medical School

Characterization of Pancreatic Cancer Stem Cells

Ethicon HPB Physiology/Biology
Lee Ocuin, MD

Memorial Sloan-Kettering Cancer Center

Immune Activation of Human Liver Dendritic Cells

2006

Ethicon HPB Physiology/Biology
Luis Garcia, MD

The Milton S. Hershey Medical Center

Targeted Inhibition of VEGF Prevents Development of Tumor Antigen-Specific T-Cell Tolerance in the Murine Liver

Sanofi-aventis HPB Oncology
Jon Cardinal, MD

University of Pittsburgh

Crossroad in Cancer Signaling: Regulation of Human iNOS Expression by the WNT B-Catenin Path

2005

Ethicon HPB Physiology/Biology
Sunil K. Geevarghese, MD

Vanderbilt University Medical Center

The Role of Mitochondrial Calcium Management in Hepatic Ischemia-Reperfusion Injury following Syngeneic Rat Liver Transplantation

Sanofi-aventis HPB Oncology
Jon Dorfman, MD

Massachusetts General Hospital

Positron Emission Tomography to Monitor HSV-2 Viral Oncolysis

2004

Ethicon HPB
Jennifer Lynn Irani, MD

Brigham and Women's Hospital

The Role of CEACAM6 in Pancreatic Cancer Invasion

2003

Ethicon HPB
Shiva Sarraf-Yazdi, MD

Duke University Medical Center

Anti-angiogenic Therapy of Murine Liver Metastases by Tie2 Inhibition

2002

Ethicon HPB
Charles M. Vollmer, MD

University of Toronto

Characterization of a Novel Translocation Breakpoint in Pancreatic Cancer

2001

Ethicon HPB
Nicole Chandler, MD

Beth Israel Deaconess Medical Center

Overcoming Chemoresistance in Human Pancreatic Cancer